2Pruszak J, Ludwig W, Blak A, et al. CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells [Jl. Stem Cells, 2009, 27(12): 2928-2940.
3Roberts Z J, Ching L M, Vogel S N. IFN-beta-dependent inhibition of tumor growth by the vascular disrupting agent 5, 6-dimethylxanthe- none-d-acetic acid (DMXAA) [ J]. J Interferon Cytokine Res, 2008, 28(3) : 133 -139.
4Wang G X, Zhan Y A, Hu H L, et al. Mesenchymal Stem Cells Modified to Express Interferon- Inhibit the Growth of Prostate Cancer in a Mouse Model[J]. J Int Med Res, 2012, 40(1) : 317 -327.
5Dvorakova J, Hruba A, Velebny V, et al. Isolation and characteriza- tion of mesenchymal stem cell population entrapped in bone marrow collection sets[J]. Cell Biol Int, 2008, 32(9) : 1116 -1125.
6Catalona W J, Richie J P, Ahmann F R, et al. Comparison ot dgtat rectal examination and serum prostate specific antigen in the early de- tection of prostate cancer: results of a muhicenter clinical trial of 6, 630 men[J]. I Uml, 1994, 151(5): 1283-1290.
7Challaeombe B, Dasgupta P, Patel U, et al. Recognizing and manag- ing the complications of prostate biopsy [ J ]. BJU Int, 2011, 108 (8) : 1233 - 1234.
8Raja J, Ramachandran N, Munneke G, et al. Current status of tran- srectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer[J]. Clin Radiol, 2006, 61 (2) : 142 -53.
9Kirkham A P, Emberton M, Allen C. How good is MRI at detecting and characterising cancer within the prostate? [ J ]. Eur Urol, 2006, 50(6) : 1163 -1174.
10Kurhanewicz J, Vigneron D B, Males R G, et al. The prostate: MR imaging and spectroscopy. Present and future [ J ]. Radiol Clin North Am, 2000, 38(1): 115- 138, viii-ix.
